1/ One day everyone will recognize #selectionbias due to a #collider and the world will be a better place. This time observational studies found a higher risk of omicron reinfection after a 3rd dose of #COVID19 vaccine. As usual, alarms went off. Can you see the obvious bias?

Flashbacks triggered at the Rheuma retreat CMM 😅

Journal Impact Factor (JCR 2023, Web of Science) of top journals in #Rheumatology. Gentle reminder: JIF shall not be used to assess the quality of individual publications💡 #RheumTwitter

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

Day 1 of the #3TR Annual Meeting, and what a fantastic and fully packed morning it has been! After inspiring talks by invited speakers and 3TR members, the meeting is in full swing now, featuring updates from the different groups. Let’s keep learning and advancing together!🥳

NEW in The Lancet—Georg Schett and colleagues discuss the evolving strategies for targeting autoreactive B cells via CAR T-cell therapy in autoimmune diseases thelancet.com/journals/lance…

What are the factors predicting renal flares in patients with SLE? Can belimumab combined with antimalarials be effective in preventing them? Find out here 👉 loom.ly/SxShRTE Alvaro Gomez Ioannis Parodis #Lupus #MedTwitter #MedEd #MedicalEducation

Happy international women’s day!! I wish for a future where we don’t need a day to remember, support and acknowledge women in society 💪 Until then we need unite and support each other instead of trying the oust one another💪 #WomenInSTEM #InternatonalWomensDay

International women’s day with such an instructive and refreshing scientific discussion between Marina Dehara and @OrianneDumas. Guided by @elizabetharkema, Marina skilfully navigated the uncharted waters of risk factors for sarcoidosis. Grattis, Dr. Dehara 🥳 #WomenInScience

🇸🇪 Reassuring study on the use of #hydroxychloroquine during pregnancy 🤰No association with malformations at dosages used in #rheumatology Thanks @elizabetharkema Elisabet Svenungsson for generating important evidence for patients! Lupus Europe MotherToBaby Karen Schreiber Laurent ARNAUD

Extremely grateful for having been part of the 4th advanced workshop on SLE SLEuro. Going back to Sweden with a bag full of fresh knowledge, memories with amazing people and pasteis de nata. Laurent ARNAUD & team: impecable organisation 🙌🏻

Do bakers daydream about leaving their job to do a PhD in molecular biology?

The 4th SLEuro Advanced Workshop on SLE was succesfully completed in Porto! Keep up-to-date to register for the next Workshop! ⏰ Check out the past editions at the bottom of the following webpage: sleuro.org/advanced-works…

🧵 After 75 years of using glucocorticoids (GC) for lupus nephritis (LN), we still don't know the most effective and safe doses. Let’s explore the data from our recent publication: acrjournals.onlinelibrary.wiley.com/doi/abs/10.100…

Check out our latest #research on #rheumatoidarthritis, published with Springer Nature in @NatureRevRheum rdcu.be/dKnUJ

Fantastic presentation from Mia Rodziewicz using BILAG-BR data: ⭐️NPSLE had higher damage / disease activity ⭐️ NPSLE more likely to have APS ab ⭐️ RTX appears effective in NPSLE (no trials)

Journal Impact Factor (JCR 2024, Web of Science) of top journals in #Rheumatology. Are we already seeing the expected after-COVID drop in JIF ? 🤔 Gentle reminder: JIF shall not be used to assess the quality of individual publications💡 #RheumTwitter

A Perspective describes how to find the balance between disease activity control and treatment-related adverse effects to safely withdraw immunosuppressants in patients with lupus nephritis in remission. bit.ly/JASN0365 Hans-Joachim Anders Brad H Rovin Andreas Kronbichler

Elegantly executed study showing how immune dysregulation precedes the debut of sarcoidosis by many years 👏 Intriguing to see the utility of protein biomarkers in identifying individuals at risk 💡

Another day, another study showing that discontinuation of biologics leads to a higher rate of recurrence/flare in RMDs. Good read! thelancet.com/journals/lance…